Table 1.
All n=445 |
Non-hospitalised n=354 | Hospitalised n=91 |
Punadjusted | |
Age (mean in years, SD) | 52.7 (17.4) | 49.3 (16.3) | 65.9 (14.8) | 1.06×10−15* |
Sex (male) (N, %) | 166 (37.3) | 133 (37.6) | 33 (36.3) | 1 |
OSA (N, %) | 38 (8.5) | 19 (5.4) | 19 (20.9) | 5.13×10−5* |
BMI (mean kg/m2, SD) | 27.13 (5.44) | 26.54 (5.20) | 29.25 (5.78) | 0.014* |
Hypertension (N, %) | 79 (17.8) | 40 (11.3) | 39 (42.9) | 5.03×10−11* |
Diabetes (N, %) | 46 (10.3) | 23 (6.5) | 23 (25.3) | 3.45×10−6* |
CHD (N, %) | 21 (4.7) | 9 (2.5) | 12 (13.2) | 5.20×10−4* |
Asthma/COPD | 54 (12.1) | 40 (11.3) | 14 (15.4) | 1 |
Differences and associations between non-hospitalised and hospitalised COVID-19 positive individuals. Baseline demographics and clinical characteristics Punadjusted values were based on χ2 test. For continuous variables, we used Student’s t-test. BMI was measured of 264 participants including 206 non-hospitalised and 58 hospitalised individuals.
*Statistically significant.
BMI, body mass index; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; OSA, obstructive sleep apnoea.